CCDHB,Research Office 13/NTA/52 Approve Supplemental PN Dr Shay McGuinness dr paul Intervention Auckland DHB Identification of risks and protective factors for long 13/NTA/53 Approve Dr Rachael Harry Auckland District Health Board Observational term outcomes following pediatric liver transplantation 13/NTA/54 Approve The CCC trial Dr Shay McGuinness Intervention Study of MK-5172 and 13/NTA/57 Approve +/- RBV in HepC Prof Edward Gane Auckland Clinical Studies Ltd Intervention patients Intravenous magnesium sulphate as an adjuvant Dr Berinder Singh 13/NTA/58 Approve therapy in exacerbations Dr saptarshi mukerji Shahpuri,Mr Bevan Intervention of chronic obstructive Clayton-Smith pulmonary disease. Associate Professor 13/NTA/59 Approve CVI Pharmacokinetic Dr Andrew Hill ADHB,Jan Adams, COO Intervention Andrew Holden GBM Immune Suppression CCDHB,Malaghan Institute of 13/NTA/61 Approve Dr. Martin Hunn Observational Study Medical Research 13/NTA/62 Approve CHINA Study Dr James Hamill Mr Stephen Adams Auckland District Health Board Intervention Is analgesia required for 13/NTA/63 Approve Dr Ben McHale Dr Ben McHale Lakes DHB Ethics committee Intervention grommet insertion? Auckland District Health Dr Andrew Hill,Dr Stewart Board,CMDHB Research Associate Professor 13/NTA/70 Approve MAJESTIC Hawkins,Dr Thodur Office,CMDHB Research Intervention Andrew Holden Vasudevan Office,Jan Adams, COO,kath phillips PSA-EPO in People with CKD Not on Dialysis or Auckland Clinical Studies 13/NTA/72 Approve Dr Janak De Zoysa Intervention Receiving Erythropoiesis Taylor, CCST Stimulating Agents
13/NTA/52 Approve Supplemental PN Dr Shay McGuinness dr paul CCDHB,Research Office Auckland DHB Intervention 13/NTA/53 Approve Identification of risks and protective factors for long term outcomes following pediatric liver transplantation Dr Rachael Harry Auckland District Health Board Observational 13/NTA/54 Approve The CCC trial Dr Shay McGuinness Intervention 13/NTA/57 Approve Study of MK-5172 and +/- RBV in HepC patients Prof Edward Gane Auckland Clinical Studies Ltd Intervention 13/NTA/58 Approve Intravenous magnesium sulphate as an adjuvant therapy in exacerbations of chronic obstructive pulmonary disease. Dr saptarshi mukerji Dr Berinder Singh Shahpuri,Mr Bevan Clayton-Smith Intervention 13/NTA/59 Approve CVI Pharmacokinetic Associate Professor Andrew Holden Dr Andrew Hill ADHB,Jan Adams, COO Intervention 13/NTA/61 Approve GBM Immune Suppression Study Dr. Martin Hunn CCDHB,Malaghan Institute of Medical Research Observational 13/NTA/62 Approve CHINA Study Dr James Hamill Mr Stephen Adams Auckland District Health Board Intervention 13/NTA/63 Approve Is analgesia required for grommet insertion? Dr Ben McHale Dr Ben McHale Lakes DHB Ethics committee Intervention 13/NTA/70 Approve MAJESTIC Associate Professor Andrew Holden Dr Andrew Hill,Dr Stewart Hawkins,Dr Thodur Vasudevan Auckland District Health Board,CMDHB Research Office,CMDHB Research Office,Jan Adams, COO,kath phillips Intervention 13/NTA/72 Approve PSA-EPO in People with CKD Not on Dialysis or Receiving Erythropoiesis Stimulating Agents Dr Janak De Zoysa Auckland Clinical Studies Taylor, CCST Intervention
northern-a-ethics-committee-annual-report-2013.docx